Puma Biotech dips on stock offering by investor

Puma Biotechnology

25/07/2022 18:29

** Shares of cancer drug maker Puma Biotechnology Inc
 PBYI.O  down 2.2% at $3.15
    ** Co files for offering of nearly 1.8 mln common shares by
existing investor, Athyrium Opportunities Associates IV
Co-Invest 2  urn:newsml:reuters.com:*:nFWN2Z40D6
    ** Athyrium's current ownership stands at 3.93%, which will
be eliminated entirely if all offered shares are sold, according
to a filing with the SEC
    ** At current levels, Athyrium's stake would fetch $5.4 mln
in proceeds
    ** As of last close, PBYI stock is up nearly 6% YTD

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com;))